Paulson John 4

What Happened John Paulson, a director of Bausch Health Companies Inc. (BHC), was granted 11,574 restricted share units (RSUs) on March 31, 2026. The grant is reported as an acquisition (Award) at an imputed value of $5.40 per RSU, totaling $62,500. These RSUs were issued in lieu of cash compensation for board service.

Key Details

• Transaction date and type: 2026-03-31 — Grant/Award of RSUs (Code A).
• Amount and value: 11,574 RSUs at $5.40 each; aggregate value reported $62,500.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Notable footnotes:
  • F1: RSUs issued in lieu of cash for the quarter ending March 31, 2026; each RSU is a contingent right to one common share.
  • F2: John Paulson is the controlling person of Paulson Capital Inc., an investment manager for certain Funds that directly own securities; he disclaims direct beneficial ownership of securities held by those Funds per Rule 16a-1(a)(4).
• Timeliness: Filing date 2026-04-02 for a 2026-03-31 grant — reported within the typical two-business-day Form 4 window (no lateness indicated).

Context RSU awards like this are routine board compensation and represent a claim to future shares (subject to vesting/conditions), not an open-market purchase or sale. The footnote indicates the award replaced cash pay and that some related securities may be held indirectly by funds managed by Paulson; the filing disclaims direct beneficial ownership of securities not personally owned.